References
- Abe T., Sato A. Reaction mechanism between aminocaproic acid and plasmin, tissue activator and trypsin. Keio J. Med. 1959; 8: 219
- Ablondi F. B., Hagan J. J., Philips M., De Renzo E. C. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by Aminocaproic acid. Arch. Biochem. 1959; 82: 153
- Albrechtsen O. K. The fibrinolytic activity of human tissues. Brit. J. Haematol. 1957; 3: 284
- Alkjaersig N., Fletcher A. P., Sherry S. δ-aminocaproic acid: an inhibitor of plasminogen activation. J. biol. Chem. 1959; 234: 832
- Andersson L., Nilsson I. M. Effect of δ-aminocaproic acid on fibrinolysis and bleeding conditions in prostatic disease. Acta chir. scand. 1961; 121: 291
- Astrup T., Albrechtsen O. K. Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. Scand. J. clin. Lab. Invest. 1957; 9: 233
- Astrup T., Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. 1952; 40: 346
- Christoffersen J. C., Ladehoff Aa. Fibrinolysis and bleeding in prostatic surgery. Urol. int. (Basel) 1961; 11: 302
- Cliffton E. E., Burchell A. R. Inhibition of fibrinolysis by hyperlipemia. Thrombos. Diathes. haemorrh. (Stuttg.) 1961; 5: 463
- Fetter T. R., Tocantins L. M., Cottone R. K., Brosseau C., Bowman W. D. Effect of epsilon aminocaproic acid on bleeding after prostatectomy. J. Urol. (Baltimore) 1961; 85: 970
- Heuson J. C., Peers W., Tagnon H. J. A new diagnostic and therapeutic approach of fibrinolysis and hemorrhage. Blood 1958; 13: 874
- Ladehoff Aa. The content of plasminogen activator in the human urinary tract. Scand. J. din. Lab. Invest. 1960; 12: 166
- Ladehoff Aa. The fibrinolytic activity of tumors of the kidney and bladder. Acta path. microbiol. scand
- Alexander B., Rasmussen J. Fibrinolysis and thromboplastic activity in relation to hemorrhage in transvesical prostatectomy. Scand. J. clin. Lab. Invest. 1961; 13: 231
- Lang K., Bitz H. Über den Stoffwechsel der δ-Aminocapronsaure. Biochem. Z. 1953; 324: 495
- Lombardo L. J. Fibrinolysis following prostatic surgery. J. Urol. (Baltimore) 1957; 77: 289
- Burstein M., Guinand A. Studies in the prevention of fibrinolysis occurring in prostatic surgery. Ibid. 1958; 79: 507
- McNicol G. P., Fletcher A. P., Alkjaersig N., Sherry S. The use of epsilon aminocaproic acid, a potent inhibitor of fibrinolytic activity, in the management of postoperative hematuria. Ibid. 1961; 86: 829
- Neft L. G., Dugdale M., Biggs A. W., Raines S. L. Treatment of abnormal bleeding associated with prostatic disease by intravenous fat emulsion. Ibid. 1961; 85: 329
- Nilsson I. M., Sjoerdsma A., Waldenström J. Antifibrinolytic activity and metabolism of δ-aminocaproic acid in man. Lancet 1960; 1322
- Nilsson I. M., Björkman S. E., Anderson L. Clinical experiences with δ-aminocaproic acid as an antifibrinolytic agent. Acta med. scand. 1961; 170: 487
- Patent Specification No. 770, 693. Her Majesty's Stationary Office, London 1957
- Rasmussen J., Albrechtsen O. K. Characterization of the fibrinolytic components in the human prostate. Scand. J. clin. Lab. Invest. 1960; 22: 261
- Sack E., Spaet T. H., Gentile R. L., Hudson P. B. Reduction of postprostatectomy bleeding by epsilon-aminocaproic acid. New Engl. J. Med. 1962; 266: 541
- Scott E. V. Z., Matthews F., Butterworth C. E., Frommeyer W. B. Abnormal plasma proteolytic activity. (Diagnosis and treatment.) Surg. Gynec. Obstet. 1954; 99: 679
- Tagnon H. J., Schulman P., Whitmore W. F., Kravitz S. C. The hemorrhagic syndrome of metastatic prostatic cancer and its treatment. J. clin. Invest. 1952; 31: 666
- Wendt H., Perlick E., Seyffarth G. H. Zur Blutung und Nachblutung bei der Prostatek-tomie. Langenbecks Arch. klin. Chir. 1957; 286: 322